ASX:RMD

ResMed

ResMed is under Algo Engine buy conditions.

ResMed is approaching a price range where we’re likely to see a new Algo Engine buy condition.

ResMed is under Algo Engine buy conditions and we see buying support building within the $30 – $33 price range.  

ResMed is under Algo Engine buy conditions and we see buying support building.

ResMed is under Algo Engine buy conditions and is now up 84% since being added to our model in October 2018.

RMD delivered a solid earnings result and upgrades to earnings are partially offset by the stronger AUD.

RMD is looking to resume share buybacks in 2H21.

We see buying support at $26 and suggest investors look to accumulate the stock.

ResMed is under Algo Engine buy conditions and we see buying support building.

ResMed will release 2Q21 earnings on Friday 29 January. 

ResMed is under Algo Engine buy conditions and we see buying support building.

ResMed will release 2Q21 earnings on Friday 29 January. 

ResMed is under Algo Engine buy conditions and we see buying support building.

ResMed will release 2Q21 earnings on Thursday 28 January

ResMed is under Algo Engine buy conditions and we see buying support building.